Pantoprazole sodium

Modify Date: 2024-01-02 09:15:08

Pantoprazole sodium Structure
Pantoprazole sodium structure
 Common Name Pantoprazole sodium
CAS Number 138786-67-1 Molecular Weight 405.35200
Density N/A Boiling Point 586.9ºC at 760 mmHg
Molecular Formula C16H14F2N3NaO4S Melting Point 199-202ºC
MSDS Chinese USA Flash Point 308.7ºC

 Use of Pantoprazole sodium


Pantoprazole sodium salt(SKF96022; Protonix) is a proton pump inhibitor drug used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.IC50 value:Target: proton pump inhibitor

 Names

Name Pantoprazole sodium
Synonym More Synonyms

 Pantoprazole sodium Biological Activity

Description Pantoprazole sodium salt(SKF96022; Protonix) is a proton pump inhibitor drug used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.IC50 value:Target: proton pump inhibitor
Related Catalog
References

[1]. http://www.drugbank.ca/drugs/DB00213

 Chemical & Physical Properties

Boiling Point 586.9ºC at 760 mmHg
Melting Point 199-202ºC
Molecular Formula C16H14F2N3NaO4S
Molecular Weight 405.35200
Flash Point 308.7ºC
Exact Mass 405.05700
PSA 94.68000
LogP 3.53580
Storage condition -20°C Freezer

 MSDS

Material Safety Data Sheet
Section1. Identification of the substance
Product Name: Pantoprazole sodium
Synonyms:
Section2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
Section3. Composition/information on ingredients.
Ingredient name:Pantoprazole sodium
CAS number:138786-67-1
Section4. First aid measures
Skin contact:Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact:Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation:Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion:Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Section5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.
Section6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution:Wear approved mask/respirator
Hand precaution:Wear suitable gloves/gauntlets
Skin protection:Wear suitable protective clothing
Eye protection:Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.
Section7. Handling and storage
Handling:This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:
Section8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.
Section9. Physical and chemical properties
Appearance:Not specified
Boiling point:No data
No data
Melting point:
Flash point:No data
Density:No data
Molecular formula:C16H14F2N3NaO4S
Molecular weight:405.4
Section10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride, sulfur oxides.
Section11. Toxicological information
No data.
Section12. Ecological information
No data.
Section13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.
Section14. Transportation information
Non-harzardous for air and ground transportation.
Section15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

SECTION 16 - ADDITIONAL INFORMATION
N/A

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DD8264000
CHEMICAL NAME :
1H-Benzimidazole, 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)me thyl)sulfinyl)-, sodium salt
CAS REGISTRY NUMBER :
138786-67-1
LAST UPDATED :
199503
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C16-H14-F2-N3-O4-S.Na
MOLECULAR WEIGHT :
405.38

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
747 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 15,801,1990
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
256 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 15,801,1990
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 15,801,1990
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
395 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 15,801,1990

 Safety Information

Hazard Codes Xn:Harmful
Risk Phrases R20/21/22-37/38-41-48
Safety Phrases S22-26-36/37/39-45
HS Code 2933990090

 Synthetic Route

pantoprazole structure

pantoprazole

CAS#:102625-70-7

~95%

Pantoprazole sodium Structure

Pantoprazole sodium

CAS#:138786-67-1

Literature: TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC. Patent: WO2004/111029 A2, 2004 ; Location in patent: Page 24 ;
Pantoprazole Sulfide structure

Pantoprazole Sulfide

CAS#:102625-64-9

~97%

Pantoprazole sodium Structure

Pantoprazole sodium

CAS#:138786-67-1

Literature: MACLEODS PHARMACEUTICALS LIMITED Patent: WO2009/66317 A2, 2009 ; Location in patent: Page/Page column 8 ;
2-{[(4-Chloro-3-methoxy-2-pyridinyl)methyl]sulfinyl}-6-(difluorom ethoxy)-1H-benzimidazole structure

2-{[(4-Chloro-3...

CAS#:409098-86-8

~70%

Pantoprazole sodium Structure

Pantoprazole sodium

CAS#:138786-67-1

Literature: Napoletano, Caterina; Porta, Eleonora; Allegrini, Pietro; Castaldi, Graziano Patent: US2005/96352 A1, 2005 ; Location in patent: Page/Page column 4 ;
5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole structure

5-(Difluorometh...

CAS#:97963-62-7

2-Chloromethyl-3,4-dimethoxypyridinium chloride structure

2-Chloromethyl-...

CAS#:72830-09-2

~82%

Pantoprazole sodium Structure

Pantoprazole sodium

CAS#:138786-67-1

Literature: CIPLA LIMITED; WAIN, Christopher, Paul Patent: WO2006/64249 A2, 2006 ; Location in patent: Page/Page column 8; 10 ;
5-(Difluoromethoxy)-2[[(4-chloro-3-methoxy-2-pyridinyl)methyl]-thio]-1H-benzimidazole structure

5-(Difluorometh...

CAS#:368890-20-4

Sodium Methylate structure

Sodium Methylate

CAS#:124-41-4

~69%

Pantoprazole sodium Structure

Pantoprazole sodium

CAS#:138786-67-1

Literature: Dipharma S.p.A. Patent: EP1518857 A1, 2005 ; Location in patent: Page/Page column 5-6 ;
Sodium hydroxide structure

Sodium hydroxide

CAS#:1310-73-2

pantoprazole structure

pantoprazole

CAS#:102625-70-7

~%

Pantoprazole sodium Structure

Pantoprazole sodium

CAS#:138786-67-1

Literature: WO2008/45777 A2, ; Page/Page column 27-28 ;

 Customs

HS Code 2933990090
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Synonyms

Pantoprazole
MFCD01658543
sodium 5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}benzimidazol-1-ide
Sodium 6-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}benzimidazol-1-ide
Pantoprazole sodium
1H-Benzimidazole, 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1)
protium
Sodium 5-(difluoromethoxy)-2-{[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl}benzimidazol-1-ide
1H-benzimidazole, 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt
Protonix
5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl) sulfinyl)-1H-benzimidazole sodium
1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1)
Pantoprazole Sodium Salt
Pantoprazole (sodium)
Top Suppliers:I want be here

Get all suppliers and price by the below link:

Pantoprazole sodium suppliers

Price: $66/10mM*1mLinWater

Reference only. check more Pantoprazole sodium price

Related Compounds: More...
Pantoprazole sodium
160488-53-9
Pantoprazole Sodium
718635-09-7
Pantoprazole sodium
102625-70-7
Pantoprazole Sodium Hydrate
164579-32-2
(R)-(+)-Pantoprazole Sodium Salt
160098-11-3
PANTOPRAZOLE N-OXIDE SODIUM SALT
1279822-90-0
Pantoprazole Sulfone N-Oxide
953787-55-8
Pantoprazole-d3
922727-37-5
Pantoprazole Sulfone
127780-16-9
1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl 2-(2-fluorophenyl)-1,3-thiazole-4-carboxylate
2248271-20-5
2-[3-(Trifluoromethyl)azetidin-1-yl]-1,3,4-thiadiazole
2877650-20-7
5-tert-butyl 4-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl) 4H,5H,6H,7H-furo[3,2-c]pyridine-4,5-dicarboxylate
2248266-82-0
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
Chemsrc provides Pantoprazole sodium(CAS#:138786-67-1) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of Pantoprazole sodium are included as well.>> amp version: Pantoprazole sodium

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved